Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5117316 | 6138944 | I | 5117316-6 | 20050701 | 20060920 | 20060929 | EXP | PHEH2006US12007 | NOVARTIS PHARMACEUTICALS CORP. | 45 | YR | M | Y | 20060928 | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5117316 | 1007715816 | PS | EXJADE | 1 | ORAL | 250 MG, QD | 21882 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5117316 | 1007715816 | MYELODYSPLASTIC SYNDROME |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5117316 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 5117316 | BONE MARROW TRANSPLANT |
| 5117316 | GRAFT VERSUS HOST DISEASE |
| 5117316 | RASH |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5117316 | 1007715816 | 20060718 | 20060811 | 36000 | MIN |